Related Experiment Video
Updated: Jul 20, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
[Mechanism of apoptosis induced by trichostatin A in leukemia Molt-4 cells analyzed by microarray]
Zhen-Ya Hong1, Li-Sha Yi, Xin-Yu Miao
1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science &Technology, Wuhan, Hubei, 430030, P. R. China.
Background & Objective:
Histone deacetylase is overexpressed in a variety of cancers and is closely correlated with oncogenic factors. A histone-deacetylase inhibitor, trichostatin A (TSA), has been shown to induce apoptosis in many cancer cells at submicromolar concentrations. However, the mechanism remains unknown. This study was to investigate the underlying mechanism of trichostatin A on apoptosis of Molt-4 cells by characterizing the global gene expression profiles before and after TSA treatment.
Methods:
PI single-labeled flow cytometry, MTT and DNA ladder were used to observe the effect of TSA on apoptosis of MOLT-4 cells and normal human peripheral blood mononuclear cells (PBMC). Microarray and reverse transcription-polymerase chain reaction (RT-PCR) and Western blot were used to detect the differentially expressed genes of Molt-4 cells after incubation with TSA.
Results:
TSA could induce apoptosis in Molt-4 cells in a dose and time-dependent manner. Besides, the dose of TSA within the time duration which could induce significant apoptosis in Molt-4 cells did not demonstrate apparent cytotoxicity to PBMCs. After incubation with TSA for 9 hours, 313 genes were detected down-regulated by microarray. Proteins encoded by these genes included signal transduction molecules, transcription factors, enzymes etc., which were involved in the regulation of cell growth, differentiation and survival. STAT5A, MYC and ikaros were down-regulated by 80.4%, 77.3% and 83.1%, respectively. The changes of the three genes were confirmed by RT-PCR and the changes of STAT5A and MYC were further confirmed by Western blot.
Conclusion:
The inhibition of cell growth and induction of apoptosis by TSA in Molt-4 cells may be due to the changes of pro-proliferation genes and anti-apoptosis genes.
Insights
Trichostatin A (TSA) induces apoptosis in Molt-4 cancer cells by down-regulating key genes involved in cell growth and survival. This histone deacetylase inhibitor shows selective toxicity, sparing normal cells.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Context:
- Histone deacetylase (HDAC) is overexpressed in various cancers, correlating with oncogenic factors.
- Histone deacetylase inhibitors like trichostatin A (TSA) induce apoptosis in cancer cells, but the mechanism is unclear.
- Molt-4 cells are a human leukemia cell line often used in cancer research.
Purpose:
- To investigate the underlying mechanism of trichostatin A (TSA)-induced apoptosis in Molt-4 cells.
- To characterize global gene expression profiles before and after TSA treatment.
- To identify specific genes and pathways affected by TSA in cancer cells.
Summary:
- TSA induces apoptosis in Molt-4 cells in a dose- and time-dependent manner, with minimal toxicity to normal human peripheral blood mononuclear cells (PBMCs).
- Microarray analysis revealed 313 down-regulated genes after 9 hours of TSA treatment, including those involved in signal transduction, transcription, cell growth, differentiation, and survival.
- Key genes such as STAT5A, MYC, and ikaros were significantly downregulated, with changes confirmed by RT-PCR and Western blot.
Impact:
- The findings suggest that TSA's anti-cancer effects stem from down-regulating pro-proliferation and anti-apoptotic genes.
- This research provides mechanistic insights into TSA's action, potentially guiding the development of novel cancer therapies.
- Understanding TSA's impact on gene expression can inform targeted therapeutic strategies for hematological malignancies.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Apoptosis
The Extrinsic Apoptotic Pathway
